KSB represents Glenmark Pharmaceuticals in acquisition of Medicamenta
Glenmark Pharmaceuticals Ltd. is the Indian leader in the development of newmolecules in mainly inflammation and metabolic disorders. The company operatesin more than eighty countries worldwide and the acquisition of Medicamenta a.s.represents a strategic entry into two of the fastest growing markets in the EU.
Other articles
Chemistry Brings People Together: KŠB at the 2026 Evening of Czech Chemistry
Czech chemistry and the chemical industry are built on innovation, responsibility and the people who drive the field forward. On Thursday, 22 October 2026, leading figures from the field and industry representatives came together at the Grand Hotel International Prague for the Czech Chemical Industry Association’s annual Evening of Czech Chemistry.
KŠB advises Smart Energies Group on transaction supporting wind power development
KŠB has advised Smart Energies Group (SEG) on a transaction with NOHO and innogy Česká republika. The transaction is intended to support the development of wind power in the Pardubice Region and is built on the synergy between wind power generation and battery energy storage.
Pavel Dejl named Czech Republic Lawyer of the Year at the Legal 500 Central & Eastern Europe Awards 2026
We are delighted to announce that KŠB partner Pavel Dejl has been named Czech Republic Lawyer of the Year at the prestigious Legal 500 Central & Eastern Europe Awards 2026.
